LoginSignup
GlaxoSmithkline logo

GlaxoSmithkline Stock

StockStock
ISIN: GB00BN7SWP63
Ticker: GSK
GB00BN7SWP63
GSK

Price

Historical dividends and forecast

All dividend data

GlaxoSmithkline has so far distributed $0.769 in 2024. The next dividend will be paid on 09.01.2025

$1.408

CHART BY

Frequently asked questions

What is GlaxoSmithkline's market capitalization?

The market capitalization of GlaxoSmithkline is $71.61B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is GlaxoSmithkline's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for GlaxoSmithkline is 22.35. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for GlaxoSmithkline?

GlaxoSmithkline's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.773. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for GlaxoSmithkline's stock?

Currently, 24 analysts cover GlaxoSmithkline's stock, with a consensus target price of $24.63. Analyst ratings provide insights into the stock's expected performance.

What is GlaxoSmithkline's revenue over the trailing twelve months?

Over the trailing twelve months, GlaxoSmithkline reported a revenue of $39.71B.

Is GlaxoSmithkline paying dividends?

Yes, GlaxoSmithkline is paying dividends. The next payment is scheduled for 09.01.2025, with an expected amount of .

What is the EBITDA for GlaxoSmithkline?

GlaxoSmithkline's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $13.54B. EBITDA measures the company's overall financial performance.

What is the free cash flow of GlaxoSmithkline?

GlaxoSmithkline has a free cash flow of $3.03B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of GlaxoSmithkline's stock?

The 5-year beta for GlaxoSmithkline is 0.61. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does GlaxoSmithkline have, and what sector and industry does it belong to?

GlaxoSmithkline employs approximately 70,212 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of GlaxoSmithkline's shares?

The free float of GlaxoSmithkline is 4.08B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $71.61B

5Y beta

 0.61

EPS (TTM)

 $0.773

Free Float

 4.08B

P/E ratio (TTM)

 22.35

Revenue (TTM)

 $39.71B

EBITDA (TTM)

 $13.54B

Free Cashflow (TTM)

 $3.03B

Pricing

1D span
$17.39$17.77
52W span
$17.03$23.13

Analyst Ratings

The price target is $24.63 and the stock is covered by 24 analysts.

Buy

12

Hold

10

Sell

2

Information

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

70,212

Biotechnology & Drugs

Health Care

Identifier

ISIN

GB00BN7SWP63

Primary Ticker

GSK

Knockouts

Join the conversation
Sign upLogin